Biogen International Neuroscience GmbH Files Patent Application for a Method of Reducing Brain Amyloid Plaques using Anti a Antibodies
The abstract of the patent published by the Controller General of Patents, Designs & Trade Marks states: "This disclosure relates to the use of anti-Ab antibody or antigen-binding fragment thereof to reduce brain amyloid plaques, or minimizes the occurrence of microhemorrhage during chronic...
Uložené v:
| Vydané v: | Indian Patents News |
|---|---|
| Médium: | Newsletter |
| Jazyk: | English |
| Vydavateľské údaje: |
New Delhi
Athena Information Solutions Pvt. Ltd
27.02.2016
|
| Predmet: | |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | The abstract of the patent published by the Controller General of Patents, Designs & Trade Marks states: "This disclosure relates to the use of anti-Ab antibody or antigen-binding fragment thereof to reduce brain amyloid plaques, or minimizes the occurrence of microhemorrhage during chronic dosing of an anti-Ab antibody or antigen-binding fragment thereof. |
|---|